Oya Guven, MD
Kırklareli, Center, 39000, Turkey (Türkiye)
NCT Number: NCT05260554
In this study, we will try to emphasize the effects of using cranberry tablets, which is an alternative to antibiotic therapy, during uncomplicated urinary tract infections (only urinary tract, bladder and kidney infections did not).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kırklareli, Center, 39000, Turkey (Türkiye)
This study was Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital Emergency Medicine Clinic and Kırklareli Training and Research Hospital Emergency Service and Internal Medicine Polyclinic. Our study; includes patients who applied to the Emergency Department and Internal Medicine outpatient clinic with the complaint of dysuria and had normal WBC, CRP, urea, and creatinine values in their analysis, and leukocyturia was found in the urine test. Two options were offered in the treatment to these patients. Vaccinium Macrocarpon Aiton preparation or fosfomycin was given for seven days. The patients were asked whether their complaints had decreased according to the Lykert-Type verbal scale at the time of admission and on the first, third, and seventh days. When the treatment was finished, leukocytes were checked in the urinalysis. This outcome was compared between the 2 treatment options. We also noted whether nausea.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this group with urinary tract inflammation; Fosfomycin was prescribed for 7 days (3 doses, 2 days apart). There are 80 patients in total.
Other names: monurol
In this group with urinary tract inflammation; 7 days (used every day) cranberry tablet was given. There are 80 patients in total.
Time frame: 7 days
After 7 days of treatment, the 2 treatment options were compared with each other.
Kırklareli University
Other
Effects of Use of Cranberry Extract Instead of Antibiotics During Uncomplicated Urinary Tract Infection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06260917
Benign Prostatic Hyperplasia, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05574257
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Iksan, Jeollabukdo, South Korea
View Trial DetailsNCT03676972
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Beijing, Beijing Municipality, China
View Trial DetailsNCT00610233
Central Nervous System Diseases, Female Urogenital Diseases
Bern, Switzerland
View Trial Details